Vasomotor Symptoms in Post-Hysterectomy Women With Ovarian Conservation: A Prospective Study
Launched by NORTHWESTERN UNIVERSITY · Jul 7, 2025
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Hysterectomies are among the most common surgical procedures for women in the United States, with approximately 600,000 operations performed annually. Traditionally, it has been assumed that retaining one or both ovaries during hysterectomy mitigates the onset and severity of vasomotor symptoms, such as hot flashes and night sweats. However, recent research indicates that even with ovarian conservation, women may experience a higher incidence of persistent vasomotor symptoms compared to those who have not had the surgery. These symptoms can significantly impact quality of life, underscoring...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. 35-50 years old
- • 2. Undergoing hysterectomy with at least one ovary conserved
- • 3. Ability to provide informed consent
- Exclusion Criteria:
- • (None specified)
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Magdy P Milad, MD MS
Principal Investigator
Northwestern Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported